SCHEMBL23969555

SCHEMBL23969555

COC(=O)C(CC(C)C)NC(=O)CNC(=O)c1cc(Cl)ccc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 15/20 0.68
PSMB8 P28062 8/20 0.68
PSMB9 P28065 8/20 0.68
PSMB6 P28072 8/20 0.68
PSMB10 P40306 8/20 0.68
PSMB1 P20618 8/20 0.68
PSMB2 P49721 8/20 0.68
PSMB11 A5LHX3 7/20 0.68
PSMA7 O14818 7/20 0.68
PSMA1 P25786 7/20 0.68
PSMA2 P25787 7/20 0.68
PSMA3 P25788 7/20 0.68
PSMA4 P25789 7/20 0.68
PSMA5 P28066 7/20 0.68
PSMB4 P28070 7/20 0.68
PSMB3 P49720 7/20 0.68
PSMA6 P60900 7/20 0.68
PSMA8 Q8TAA3 7/20 0.68
PSMB7 Q99436 7/20 0.68
NFKB1 P19838 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20257210 0.89 PSMB5 (0.63) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL20257209 0.88 PSMB5 (0.71) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL20510120 0.88 PSMB5 (0.71) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL30731585 0.88 PSMB5 (0.71) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL16271866 0.85 PSMB5 (0.74) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL19934853 0.85 PSMB5 (0.74) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL23969556 0.83 PSMB5 (0.57) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL28448221 0.83 PSMB5 (0.57) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL29359705 0.83 PSMB5 (0.57) PSMB5PSMB8PSMB9PSMB6PSMB10
SCHEMBL20117910 0.83 PSMB5 (0.71) PSMB5PSMB8PSMB9PSMB6PSMB10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220024949-A1 CU-AND NI-CATALYZED DECARBOXYLATIVE BORYLATION REACTIONS THE SCRIPPS RESEARCH INSTITUTE 2022-01-27 US disclosed
US-11161859-B2 Cu- and Ni-catalyzed decarboxylative borylation reactions THE SCRIPPS RESEARCH INSTITUTE (US) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161859-B2 Cu- and Ni-catalyzed decarboxylative borylation reactions PCSK9, LIPA, ACSL3 PSMB5 1671/4885PSMB8 2427/4885PSMB9 688/4885
US-20220024949-A1 CU-AND NI-CATALYZED DECARBOXYLATIVE BORYLATION REACTIONS PCSK9, PCSK7, PCSK6 PSMB5 1450/4885PSMB8 2210/4885PSMB9 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.